Please wait

0001601830Recursion Pharmaceuticals, Inc.333-284878S-3424B7EX-FILING FEESN/AN/Axbrli:sharesxbrli:pureiso4217:USD000160183012025-08-292025-08-2900016018302025-08-292025-08-29

Exhibit 107

Filed Pursuant to Rule 424(b)(7)

Registration No. 333-284878

Calculation of Filing Fee Tables

S-3

(Form Type)

Recursion Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

CALCULATION OF REGISTRATION FEE

						Security Type			Security Class Title			Fee Calculation or Carry Forward Rule			Amount Registered			Proposed Maximum Offering Price Per Unit			Maximum Aggregate Offering Price			Fee Rate			Amount of Registration Fee
Newly Registered Securities
Fees to be Paid			1			Equity			Class A Common Stock, par value $0.00001 per share			457(r)			2,397,023			$4.77			$11,433,499.71			$	0.00015310		$	1,750.51
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities
									Total Offering Amounts:												$11,433,499.71						$	1,750.51
									Total Fees Previously Paid:																		$	0.00
									Total Fee Offsets:																		$	0.00
									Net Fee Due:																		$	1,750.51

Offering Note

(1)    In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), Recursion Pharmaceutics, Inc. (the “Registrant”) initially deferred payment of all of the registration fees for the registration statement on Form S-3ASR (File No. 333- 284878), filed on February 12, 2025 (the “Registration Statement”). This “Calculation of Filing Fee Table” shall be deemed to update the “Calculation of Registration Fee” table in the Registration Statement. The prospectus to which this Exhibit is attached is a final prospectus supplement for the related offering. The maximum offering price per share was estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the Registrant’s Class A Common Stock on the Nasdaq Global Select Market on August 29, 2025.